BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34665435)

  • 1. Trends in adjuvant therapy after breast-conserving surgery for ductal carcinoma in situ of breast: a retrospective cohort study using the National Breast Cancer Registry of Japan.
    Yotsumoto D; Sagara Y; Kumamaru H; Niikura N; Miyata H; Kanbayashi C; Tsuda H; Yamamoto Y; Aogi K; Kubo M; Tamura K; Hayashi N; Miyashita M; Kadoya T; Saji S; Toi M; Imoto S; Jinno H
    Breast Cancer; 2022 Jan; 29(1):1-8. PubMed ID: 34665435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.
    Sagara Y; Freedman RA; Wong SM; Aydogan F; Nguyen A; Barry WT; Golshan M
    Breast Cancer Res Treat; 2017 Nov; 166(2):583-592. PubMed ID: 28776282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
    Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
    Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma In Situ.
    Park HL; Chang J; Lal G; Lal K; Ziogas A; Anton-Culver H
    Clin Breast Cancer; 2018 Apr; 18(2):e179-e185. PubMed ID: 28941977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
    Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
    Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
    Sagara Y; Freedman RA; Vaz-Luis I; Mallory MA; Wong SM; Aydogan F; DeSantis S; Barry WT; Golshan M
    J Clin Oncol; 2016 Apr; 34(11):1190-6. PubMed ID: 26834064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in the Treatment of Ductal Carcinoma in Situ.
    Barrio AV; Van Zee KJ
    Annu Rev Med; 2017 Jan; 68():197-211. PubMed ID: 28099081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receipt of mastectomy and adjuvant radiotherapy following breast conserving surgery (BCS) in New Zealand women with BCS-eligible breast cancer, 2010-2015: an observational study focusing on ethnic differences.
    Bartholomew K; Ghafel M; Tin Tin S; Aye PS; Elwood JM; Hardie C; Scott N; Kidd J; Ramsaroop R; Campbell I
    BMC Cancer; 2023 Aug; 23(1):766. PubMed ID: 37592208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast; 2014 Feb; 23(1):63-8. PubMed ID: 24291376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
    Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
    JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breast.
    Gennaro M; De Santis MC; Mariani L; Lo Vullo S; Cappelletti V; Agresti R; Cortinovis U; Paolini B; Di Cosimo S; Carcangiu ML; Daidone MG; Lozza L
    Breast; 2017 Oct; 35():63-68. PubMed ID: 28651115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy.
    Pawloski KR; Tadros AB; Sevilimedu V; Newman A; Gentile L; Zabor EC; Morrow M; Van Zee KJ; Kirstein LJ
    Breast Cancer Res Treat; 2021 Apr; 186(3):617-624. PubMed ID: 33675490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population.
    Alaeikhanehshir S; Schmitz RSJM; van den Belt-Dusebout AW; van Duijnhoven FH; Verschuur E; van Seijen M; Schaapveld M; Lips EH; Wesseling J;
    Breast Cancer Res Treat; 2024 Feb; 204(1):61-68. PubMed ID: 37964135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival benefit of postoperative radiotherapy for ductal carcinoma in situ after breast-conserving surgery: a Korean population-based cohort study.
    Kim BH; Ko BK; Bae JW; Nam S; Park MH; Jeong J; Lee HJ; Chang JH; Kim S; Hwang KT
    Breast Cancer Res Treat; 2019 Nov; 178(1):105-113. PubMed ID: 31346856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Breast Cancer Audit: ductal carcinoma in situ management in Australia and New Zealand.
    Cuncins-Hearn A; Boult M; Babidge W; Zorbas H; Villanueva E; Evans A; Oliver D; Kollias J; Reeve T; Maddern G
    ANZ J Surg; 2007; 77(1-2):64-8. PubMed ID: 17295824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.
    Chuwa EW; Tan VH; Tan PH; Yong WS; Ho GH; Wong CY
    ANZ J Surg; 2008; 78(1-2):42-8. PubMed ID: 18199204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary treatment of ductal carcinoma in situ of the breast.
    Mokbel K
    Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery and adjuvant radiotherapy for unilateral ductal carcinoma in situ (DCIS) in women aged over 70 years: A population based cohort study.
    Jauhari Y; Gannon MR; Tsang C; Horgan K; Dodwell D; Clements K; Medina J; Tang S; Pettengell R; Cromwell DA
    Eur J Surg Oncol; 2019 Aug; 45(8):1378-1387. PubMed ID: 30878169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribing practices of endocrine therapy for ductal carcinoma
    Chaudhry AT; Koulis TA; Speers C; Olson RA
    Curr Oncol; 2018 Apr; 25(2):133-138. PubMed ID: 29719429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in treatment for ductal carcinoma in situ in elderly women.
    Gold HT; Dick AW
    Med Care; 2004 Mar; 42(3):267-75. PubMed ID: 15076826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.